The B cell antigen receptor (BCR) is a multiprotein complex expressed on the surface of B cells that transmits critical signals for the development, proliferation and activation of B cells. The BCR consists of two identical immunoglobulin heavy chains (HCs) and two identical light chains (LCs) that form the antigen-binding molecule, which is associated with the signal-transduction unit composed of a heterodimer of the immunoglobulin α-chain (CD79a) and immunoglobulin β-chain (CD79b) 1 . Signaling from the BCR is triggered by the engagement of ligands and leads to activation of the B cell. The BCR lacks intrinsic tyrosine-kinase activity, but signaling is achieved by phosphorylation of its immunoreceptor tyrosine-based activation motifs (ITAMs) 2 by the tyrosine kinases Lyn (a member of the Src family) and Syk 3 . The recruitment of Syk to phosphorylated ITAMs amplifies signal transduction via the BCR 4 .
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BCR signaling ensures the generation of a naive antibody repertoire from which autoreactive specificities have been removed 5 . During early B cell development in the bone marrow (BM), gene segments encoding the immunoglobulin variable regions are stochastically recombined, which generates an enormous diversity of antibody specificities (1 × 10 11 ) 6, 7 . This process can generate BCRs that recognize the body's self components and potentially leads to autoimmunity. For silencing of those autoreactive BCRs, central tolerance is established by mechanisms such as deletion, anergy and receptor editing 8, 9 .
It has been estimated that 25-50% of the naturally arising antibodies in mice undergo receptor editing by LC replacement 10, 11 . In humans, up to 75% of the newly generated antibodies are potentially self-reactive but are efficiently removed during B cell development 12 . Diminished BCR signaling impairs the counter-selection of autoreactive B cells by failing to induce tolerance mechanisms in immature B cells in mice and humans [13] [14] [15] .
Immature B cells exclusively express immunoglobulin M BCRs (IgM-BCRs), whereas mature B cells co-express both IgM-BCRs and IgD-BCRs of identical antigen specificity. Both IgM-BCRs and IgD-BCRs form nanoclusters on the surface of resting B cells ('protein islands') [16] [17] [18] [19] [20] . The IgM-BCRs and IgD-BCRs reside in different class-specific membrane compartments with distinct compositions of protein and lipid [18] [19] [20] . The IgD compartment shows enrichment for ordered lipid domains, while the IgM-BCR gains access to such lipids only after the activation of B cells. Published reports suggest that nanoclustering of BCRs is important for shaping BCR signaling 18, 20 . So far, little is known about how such membrane organization is regulated at the molecular level.
Caveolin-1 (Cav1) is a membrane protein that promotes the assembly and stability of ordered lipid domains in several cell types 21 . In addition, Cav1 modulates the assembly and activity of multimolecular signaling complexes through interactions with its phosphorylated Tyr14 residue or its scaffolding domain 21, 22 . Increased lipid mobility, an enhanced abundance of ordered domains and accelerated endocytosis have been reported in cells lacking Cav1 expression [23] [24] [25] . It was initially reported that lymphocytes do not express Cav1, on the basis of the analysis of several B cell and T cell lines 26 . However, subsequent studies have proven a role for Cav1 in primary T cells 27, 28 . Furthermore, Cav1 has been detected in splenic B cells stimulated with lipopolysaccharide (LPS), and is seems to have a role in T cellindependent antibody responses in vivo 29 .
Given the role of Cav1 in membrane compartmentalization, we hypothesized that Cav1 regulates the nanoscale distribution IgMBCRs and IgD-BCRs on the surface of B cells. Our results showed that the IgM-BCR gained access to domains enriched for GM1 glycolipids after triggering of the BCR by a process that was regulated by the phosphorylation of Cav1 by kinases of the Src family. Accordingly, the activation of mature Cav1 −/− B cells in vivo and ex vivo was impaired, and Cav1 −/− immature B cells showed diminished receptor editing, which resulted in a skewed BCR repertoire of immunoglobulin-µ HCs (µHCs) with hallmarks of poly-and auto-reactivity. Correspondingly, Cav1 −/− mice exhibited splenomegaly, high titers of serum autoantibodies, spontaneous formation of germinal centers (GC) and a shortened lifespan.
RESULTS

Cav1 regulates nanoclustering of IgM-BCRs
Primary B cells expressed Cav1 (Supplementary Fig. 1a) . Therefore, we investigated whether Cav1 regulates the nanoscale organization of IgM-BCRs and IgD-BCRs on the surface of B cells. We performed an in situ proximity-ligation assay (PLA) with non-permeabilized primary B cells from C57BL/6 wild-type mice (B6.WT) and C57BL/6 mice deficient in Cav1 (B6.Cav1KO mice) 30 to quantify the proximity of the BCR to the cholera toxin B subunit (CTxB) on the B cell surface (Supplementary Fig. 1b ). CTxB binds with high affinity to GM1 glycolipids, for which cholesterol-and sphingolipid-rich membrane domains show enrichment ('ordered lipid domains') 31 . The control samples were resting or pervanadate (perV)-stimulated primary B cells (Supplementary Fig. 1c) . As reported 18 , in resting wild-type splenic B cells, the IgM-BCR was mainly excluded from GM1-enriched domains (Fig. 1a) . However, in resting Cav1-deficient B cells (from B6.Cav1KO mice), a significant proportion of IgM-BCRs were found in close proximity to GM1 (Fig. 1a) . On the surface of wildtype B cells, the proximity of the IgM-BCR to GM1-enriched lipid domains reached a maximum at 5 min after triggering of the BCR and decreased to basal levels after 20 min, probably due to the internalization of BCRs (Supplementary Fig. 1d ). On Cav1-deficient B cells, the already close proximity of IgM-BCR to GM1 remained unchanged after stimulation either with antibody to the BCR (anti-BCR) or with perV (Fig. 1a) . Cav1 was next expressed in the Cav1-deficient mouse B cell line K46 in a gain-of-function approach ( Supplementary Fig.  1e,f) . Again, the IgM-BCR gained access to GM1-enriched lipid domains upon B cell activation only in K46 cells expressing Cav1, as noted by PLA (Supplementary Fig. 1e ) and by purification of detergent-resistant membranes (DRMs) (Supplementary Fig. 1f) . Lack of Cav1 did not globally disrupt membrane topology, since the basal amount of DRM-associated molecules, such as GM1 and LYN, was similar in cells expressing Cav1 or a Cav1 mutant that cannot be phosphorylated and in cells lacking Cav1 expression ( Supplementary  Fig. 1f ). BCR-induced translocation of the actin-remodeling GTPase Rac1 to DRMs, which is required for its activation, occurred only in the presence of Cav1 (Supplementary Fig. 1f) , which suggested defective BCR-induced signaling in Cav1-deficient B cells. Thus, Cav1 regulated the nanoscale distribution of the IgM-BCR both in the resting state and after stimulation of the BCR.
Phosphorylation of Cav1 regulates BCR nanoclustering
We next investigated the role of the Src family of kinases in the reorganization of IgM-BCRs after activation of the BCR by incubating primary B cells with the Src-kinase inhibitor PP2. Translocation of the IgM-BCR to GM1-enriched lipid domains in Cav1 +/+ B cells was significantly blocked in the presence of PP2, comparable to the blockade seen in their Cav1-deficient counterparts (Fig. 1b) . The Src family of kinases has been reported to phosphorylate both the BCR 32 and Cav1 at Tyr14 (ref. 33) . To clarify whether phosphorylation of Cav1 regulates the membrane compartmentalization of IgM-BCR, we purified B cells from mice expressing mutant Cav1 that cannot be phosphorylated (C57BL/6 Cav1 Y14F/Y14F mice; called 'B6.Cav1 Y14F/Y14F ' here) 28 . Both the steady-state distribution of the IgM-BCR, relative to GM1-enriched lipid domains, and its activation-induced distribution were modulated by phosphorylation of Cav1 at Tyr14 (Fig. 1c) . IgM-BCRs and IgD-BCRs are found in separated class-specific compartments in wild-type B cells that coalesce only after B cell stimulation 34 . The proportion of IgD-BCRs near GM1-enriched lipid domains was significantly lower in resting B6.Cav1KO splenic B cells than in resting wild-type splenic B cells (Fig. 1d) . Stimulation of the BCR reduced the proximity of the IgD-BCR to GM1-enriched lipid domains in wild-type B cells but not in B6.Cav1KO or B6.Cav1 Y14F/Y14F B cells (Fig. 1d) , which indicated that the activation-induced distribution of IgD-BCRs was regulated by phosphorylation of Cav1 at Tyr14. The steady-state class-specific separation of the IgM-BCR nanoclusters from the IgD-BCR nanoclusters was perturbed both in B6.Cav1KO B cells and B6.Cav1 Y14F/Y14F B cells (Fig. 1e) . After stimulation of the BCR, the coalescence of IgM-BCRs and IgD-BCRs was diminished in B6.Cav1 Y14F/Y14F B cells and was abolished in B6.Cav1KO B cells (Fig. 1e) . Notably, the steady-state surface expression of the IgM-BCR and IgD-BCR and the BCR-internalization kinetics were indistinguishable in wild-type B cells, B6.Cav1KO B cells and B6.Cav1 Y14F/Y14F B cells (Supplementary Fig. 2a,b) . Thus, phosphorylation of Cav1 at Tyr14 was required for the steady-state separation of IgM-BCRs from IgD-BCRs and for the optimal reorganization of both BCR isotypes after stimulation.
The BCR gains proximity to Cav1 after B cell activation Next we used in situ PLA to investigate whether the cytoplasmic part of the BCR (the immunoglobulin α-chain) also gained proximity to Cav1 after triggering of the BCR in permeabilized cells ( Supplementary  Fig. 2c,d) . In resting primary B cells, the cytoplasmic part of the BCR and Cav1 were >40 nm apart, as no PLA signal was detected (Fig. 2) . After activation of B cells, the BCR and Cav1 gained proximity to each other gradually for the first 15 min after stimulation (Fig. 2) . This proximity was induced by treatment with anti-IgM or perV but was independent of the phosphorylation of Cav1 at Tyr14 (Fig. 2) . Similar results were obtained with K46 cells expressing Cav1 ( Supplementary  Fig. 2e) . Thus, the activation of B cells was accompanied by greater proximity between the cytoplasmic regions of the BCR and Cav1, and this reorganization did not require phosphorylation of Cav1 at Tyr14. These results were compatible with lateral reorganization of the BCR within the plasma membrane and with conformational changes in the immunoglobulin α-chain cytoplasmic tail 35 .
Diminished B cell activation in mice lacking Cav1
Our results showed that in the absence of Cav1, the nanodistribution of the IgM-BCRs and IgD-BCRs was altered. To investigate the 1 1 5 2 VOLUME 18 NUMBER 10 OCTOBER 2017 nature immunology A r t i c l e s implications for B cell activation in vivo, we used two Cav1-deficient models that differ in the Cav1 exon disrupted and their genetic background: disruption of exon 3 on the C57BL/6 background (B6. Cav1KO) 30 , or disruption of exon 2 on a mixed background (129/Sv, C57BL/6J and SJL; called 'Cav1KO' here) 36 . B6.Cav1KO and Cav1KO mice were immunized with the T cell-independent antigen nitrophenol (NP)-Ficoll, precipitated with alum. The proportion of antigen-specific B cells was significantly lower in the spleen of both Cav1-deficient models than in their wild-type counterparts (Fig. 3a,b and Supplementary Fig. 3a,b) . Furthermore, the clonal expansion of splenic B cells, as measured by staining of the proliferation marker Ki67, was also lower in both Cav1-deficient models than in their wildtype counterparts ( Fig. 3c and Supplementary Fig. 3c ). The abundance of NP-specific antibody-secreting cells and NP-specific serum antibodies was significantly also lower in both Cav1-deficient models than in their wild-type counterparts (Fig. 3d,e) . In agreement with a published report 29 , no differences were observed for T cell-dependent responses (data not shown). B6.Cav1KO 2 (10 µg/ml) plus anti-IgD F(ab′) 2 (10 µg/ml), assessing the proximity of the IgM-BCR to the IgD-BCR. Right, microscopy as in a. P < 0.0001, unstimulated B6.Cav1 Y14F/Y14F and B6.Cav1KO versus B6.WT (ANOVA). Scale bars, 5 µm. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and ****P ≤ 0.0001 (unpaired Student's t-test (comparison of only two conditions) or ANOVA followed by Dunnett's multiple-comparisons test). Data are pooled from at least three experiments with at least 300 cells per condition in each (mean + s.e.m.).
To address whether impaired BCR-induced signaling was responsible for the diminished in vivo responses, we performed ex vivo stimulation of splenic B cells. First, BCR-induced proliferation was lower in both Cav1-deficient models than in their wild-type counterparts, whereas stimulation with LPS resulted in substantial proliferation in both Cav1-deficient models equivalent to that in their wild-type counterparts ( Fig. 3f and Supplementary Fig. 3d ), which indicated that signaling from the BCR was specifically affected. Second, B cells from both Cav1-deficient models showed lower BCR-induced expression of the early activation markers CD69 and CD86 than that of their wild-type counterparts (Fig. 3g,h and Supplementary Fig. 3e ). Third, calcium-flux responses after triggering of BCR were diminished in primary cells lacking Cav1 in both models, relative to the responses in their wild-type counterparts ( Fig. 3i and Supplementary Fig. 3f ). Finally, phosphorylation of Syk, which is crucial for signal transduction from the BCR, was lower in Cav1-deficient B cells than in wildtype cells (Fig. 3j) . B6.Cav1 Y14F/Y14F B cells exhibited a less altered phenotype in terms of BCR-induced signaling (Fig. 3g,h,j) . Hence, the activation of B cells was diminished both in vivo and ex vivo in the absence of Cav1, as shown by two independent mouse models of Cav1 deficiency.
Aged Cav1-deficient mice develop features of autoimmunity Cav1-deficient mice have a shortened lifespan that has been attributed to secondary complications such as pulmonary fibrosis, hypertension or cardiac hypertrophy 37 . We confirmed those data ( Supplementary  Fig. 4a ) and extended the findings to the B6.Cav1KO model (Fig. 4a) . Mutant mice of both models (B6.Cav1KO and Cav1KO) exhibited large spleens, which were detectable from 15 weeks of age onward and became more obvious in aged mice (>30 weeks of age) ( Fig. 4b and Supplementary Fig. 4b,c) . Both the total number of B cells and the proportion of B cells in the spleen were significantly greater in Cav1-deficient mice than in their wild-type counterparts (Fig. 4c,d and Supplementary Fig. 4d ). For aged mice, the abundance of spontaneously generated GCs and class-switched B cells was significantly greater in Cav1-deficient mice than in their wild-type counterparts (Fig. 4e,f and Supplementary Fig. 4e,f) . Proliferating Ki67 + B cells formed morphological structures that resembled clonally expanding B cells in the spleen of aged mice (Supplementary Fig. 4g ). The abundance of IgG immunocomplexes in the kidneys was greater in aged Cav1-deficient mice than in their age-matched wild-type counterparts ( Fig. 4g and Supplementary Fig. 4i,j) . Aged Cav1-deficient mice had significantly higher serum titers of spontaneously generated anti-cardiolipin and IgG autoantibodies to double-stranded DNA (dsDNA) than those of their aged-matched wild-type counterparts, while their concentration of total IgG was similar to that of their age-matched wild-type counterparts ( Fig. 4h and Supplementary Fig. 4h) . No significant abnormalities were found in the myeloid or T cell lineages (data not shown). Thus, aged Cav1-deficient mice developed features of immunological dysregulation characterized by spontaneous GC formation, an increased number of B cells in the spleen, elevated titers of serum autoantibodies and shorter lifespan.
B cell-specific autoimmunity in Cav1-deficient mice Our data showed immunological dysregulation in two mouse models of Cav1 deficiency. We next generated BM chimeras to investigate the contribution of B cells to this phenotype. First, sublethally irradiated immunodeficient Rag2 −/− Il2rg −/− mice (called 'Rag2 −/− γc −/− mice' here) reconstituted with Cav1KO BM showed a significantly shorter lifespan than that of their counterparts reconstituted with wild-type BM (P = 0.04; Supplementary Fig. 5a,b) , which proved that the shorter lifespan previously reported for Cav1 −/− mice 37 resulted from their dysregulated immune system. After 25 weeks, the surviving mice were killed and analyzed. The spleen of chimeras reconstituted with Cav1KO cells showed significantly enlargement (P = 0.01; Supplementary Fig. 5c ), and the frequency of spontaneously generated GC B cells was greater (P = 0.06; Supplementary  Fig. 5d ), relative to that of their counterparts in mice reconstituted with wild-type cells. Significantly higher titers of IgG antibodies to cardiolipin (P = 0.005) and to dsDNA (P = 0.05) were detected in mice reconstituted with Cav1KO cells than in those reconstituted with wild-type cells (Supplementary Fig. 5e ). Hence, the immunological dysregulation in Cav1-deficient mice had its origin in their immune system.
We performed competitive BM reconstitution to confirm those findings and to narrow down the population responsible for that phenotype. Rag2 −/− γc −/− mice were reconstituted with B6.Cav1KO BM cells or C57BL/6 wild-type (B6.WT) BM cells (each expressing the congenic marker CD45.2) together with wild-type BM cells (expressing CD45.1; CD45.1WT) at a cell ratio of 1:1. In the B6.Cav1KO-CD45.1WT chimeras, 73% ± 3% (mean ± s.e.m.) of the B cells in the BM were Cav1-deficient (B6.Cav1KO) cells (Fig. 5a ). Significant accumulation of Cav1-deficient B cells was detected from the immature B cell stage onward (Fig. 5b) . Similarly, Cav1-deficient cells constituted 71% ± 2% of splenic lymphocytes, whereas wild-type cells accounted for the expected 49% ± 0.6% of splenocytes, in the B6.WT-CD45.1WT chimeras (Fig. 5c,d ). In the peripheral lymph nodes, Cav1-deficient B cell populations were also specifically expanded (Fig. 5e) , whereas A r t i c l e s the proportion of various T cell populations conserved the 1:1 ratio in in the spleen, lymph nodes and thymus of both chimeras ( Fig. 5f and Supplementary Fig. 5f-i) . When spontaneously formed GC B cells were analyzed, up to 73% ± 6% of them lacked Cav1 expression in the B6.Cav1KO-CD45.1WT chimera (Fig. 5g) . Moreover, the B6.Cav1KO-CD45.1WT chimeras exhibited higher titers of serum autoantibodies than did the B6.WT-CD45.1WT chimeras (Fig. 5h) . ). *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001 (unpaired Student's t-test (except where stated otherwise); presented as in Fig. 1 ). Data are representative of two independent experiments (a-c,f,i; mean + s.e.m. in f), or three independent experiments (j) or are pooled from two independent experiments (d,e,g,h; mean + s.e.m. in g,h).
shorter than that of mice reconstituted with B6.WT BM (Fig. 5i) . The surviving mice reconstituted with B6.Cd79a −/− BM plus B6.Cav1KO BM had a specifically expanded B cell compartment in the spleen (Fig. 5j) and elevated serum IgG autoantibodies directed against cardiolipin (Fig. 5k) , relative to such parameters in mice reconstituted with B6.Cd79a −/− BM plus B6.WT BM. The onset of the immunological dysregulation was delayed in the mice reconstituted with B6.Cd79a −/− BM plus B6.Cav1KO BM relative to that in mice reconstituted with only Cav1-deficient BM (data not shown), which suggested that Cav1 deficiency in other immune cells, in addition to B cells, might aid in the development of the phenotype observed.
Defective central tolerance in B6.Cav1KO mice Central B cell-tolerance checkpoints and peripheral B cell-tolerance checkpoints ensure the removal of autoreactive B cells in the BM and periphery, respectively 12 . To identify whether such checkpoints were defective in B6.Cav1KO mice, we purified immature B cells from the BM and splenic B cells and then cloned and sequenced transcripts from their productive Igh allele. The variable domains of B6.Cav1KO
B cells carried longer complementarity-determining CDR3 segments harboring more positively charged amino acids than did such domains in their B6.WT counterparts ( Fig. 6a and Supplementary  Fig. 6a ). Such features are a hallmark of autoreactivity 12 . Autoreactive immunoglobulin HCs were detected in immature B6.Cav1KO B cells from the BM (Fig. 6a) , in support of the proposal of a defect in central tolerance. Cav1 mRNA was significantly more abundant in immature B cells than in B cells at other developmental stages (Fig. 6b) . B cell development in B6.Cav1KO BM was unaltered (relative to that in B6.WT BM), with two exceptions: first, a increase specifically in mature recirculating B cells (Fig. 6c) , and second, a reduced proportion of cells expressing the λ-light chain (λLC) (10% reduction; Supplementary Fig. 6b ). The frequency of transitional CD93 + B cells in the spleen was lower and the proportion of anergic B cells was greater in B6.Cav1KO mice than in B6.WT mice (Supplementary Fig.  6c ). Together these data supported the proposal of a break in central tolerance but partially functional peripheral tolerance, which would explain the development of features of autoimmunity rather late in life in Cav1-deficient mice. 
A r t i c l e s
In immature B cells, newly generated BCRs are tested for autoreactivity by means of BCR signaling. We thus investigated whether Cav1 also regulates the nanoclustering of IgM-BCRs in immature B cells. The proximity of the IgM-BCR to GM1-enriched membranes increased after stimulation in immature B6.WT B cells but was impaired by the expression of the mutant Cav1 that cannot be phosphorylated (Cav1Y14F) or the absence of Cav1 (Fig. 7a) . The immature B cell line WEHI-231 (called 'WEHI' here) has proven to be a useful model for the study of BCR-induced apoptosis and clonal deletion of immature B cells. WEHI cells barely express Cav1, as described for other lymphoid cell lines 26 . In a gain-of-function experiment, a vector containing an internal ribosomal entry site plus sequence encoding green fluorescent protein (GFP) and Cav1 or a vector containing that internal ribosomal entry site plus sequence encoding GFP alone was expressed in WEHI cells. IgM-BCR and GM1-enriched membranes coalesced and BCR and Cav1 gained proximity upon activation only in the cells expressing Cav1 ( Supplementary  Fig. 7a,b) . When WEHI cells were stimulated with anti-IgM, successfully transduced (GFP + ) cells expressing Cav1 underwent a stronger apoptosis response than that of their GFP − counterparts ( Supplementary  Fig. 7c ). Our data suggested that by compromising reorganization and signaling via the IgM-BCR at the membrane, Cav1 deficiency affected the efficient removal of autoreactive immature B cells.
We next established an in vitro system that mimicked the encounter of an autoantigen with immature B cells. BM from B6.Cav1KO and B6.WT mice was cultivated under conditions in which B220 + IgM + immature B cells were present (Supplementary Fig. 7d) . Next, the F(ab′) 2 fragment of anti-IgM was added to the BM cultures, to mimic autoantigen. The proportion of IgM-expressing cells and surface expression of IgM-BCR were reduced only for B6.WT cells, not for B6.Cav1KO cells (Supplementary Fig. 7d,e) . After activation of immature B cells via the BCR, efficient receptor editing leads to an increased use of λLCs 38 . Immature B6.Cav1KO B cells failed to increase their λLC expression after being activated in vitro (Fig. 7b) . Next, B6.Cav1KO mice were crossed with 3-83Igi mice, which express Igh and Igk loci targeted with genes that encode an autoreactive BCR composed of a 3-83Hi HC and a 3-83κi LC 39 . The 3-83 BCR is autoreactive on the H-2 b (B6) background. The proportion of λLC + B cells is the best indicator of receptor editing in this model, since pairing of a wild-type κLC with a 3-83Hi HC creates a high frequency of autoreactive receptors. Three groups of littermates were analyzed: mice expressing both the 3-83 HC and 3-83 LC (3-83Hi-3-83κi), mice expressing the 3-83 HC and a wild-type LC (3-83Hi-WT), and mice expressing a wild-type HC and the 3-83 LC (WT-3-83κi). The frequency of λLC + cells in WT-3-83κi mice was similar to that of non-transgenic mice (Fig. 7c,d and data not shown), which indicated that pairing of the endogenous HC with the 3-83κi LC did not create autoreactive receptors. Pairing of the 3-83Hi HC with the wildtype LC (83Hi-WT), in contrast, generated autoreactive receptors, as demonstrated by a significantly greater frequency of λLC + B cells in 83Hi-WT mice than in WT-3-83κi or non-transgenic mice (Fig. 7c,d and data not shown). The greatest frequency of λLC + cells was observed in 3-83Hi-3-83κi mice (Fig. 7c,d) . The frequency of λLC + B cells was lower in Cav1-deficient (B6.Cav1KO) mice expressing the 3-83Hi-3-83κi or 3-83Hi-WT BCR than in their Cav1-sufficient (B6.WT) counterparts (Fig. 7c,d ). Together our data support a model in which Cav1 regulates the nanoscale distribution of the BCR and thereby controls BCR activation. In immature B cells, defects in this distribution result in sub-optimal receptor editing, which leads to a break in B cell tolerance.
DISCUSSION
Our data have demonstrated that Cav1 regulated the following hallmarks of the nanoclustering of IgM-BCRs and IgD-BCRs on the surface of resting B cells: first, efficient exclusion of the IgM-BCR from GM1-enriched lipid domains; second, close proximity of the IgD-BCR to those lipids; and third, class-specific segregation of IgMBCRs from IgD-BCRs. Thus, the previously described organization of the IgM-BCR and IgD-BCR protein islands or nanoclusters [16] [17] [18] 20, 34, 40 requires Cav1. We have identified Cav1 as a molecular target that allows manipulation of the nanoscale organization of the B cell plasma membrane. Whether Cav1 orchestrates this basal compartmentalization during the sorting process at the Golgi apparatus or by scaffolding the IgD-BCR in GM1-enriched lipid domains, while excluding the IgM-BCR, remains to be investigated. Likewise, the motifs of the IgM-BCR and IgD-BCR that mediate this class-specific compartmentalization must be identified. Notably, cholesterol-and sphingolipid-rich domains exist in the absence of Cav1 in several cell types, including lymphocytic cell lines 26 , and we showed here that the composition of these domains was not altered substantially in Cav1-deficient B cells. Therefore, it is very unlikely that our results were just a consequence of the lack of these domains in Cav1-deficient B cells. At steady state, nanoclustering of BCRs was regulated by phosphorylation of Cav1 at Tyr14. Cav1 is phosphorylated in resting B cells 41 and might recruit the Src kinase CSK 42 to mediate actin organization 43 and thereby prevent the diffusion of BCRs in the plasma membrane 20 .
The stimulation of BCRs results in rapid coalescence of IgMBCRs with GM1-enriched domains 44 , diffusion of IgD-BCRs from those domains 18 and coalescence of nanoclusters of IgM and IgD 34 . Treatment of B cells with the F-actin inhibitor latrunculin A results in cell activation 20 , which suggests that relaxing the actin cytoskeleton promotes diffusion in the membrane and the coalescence of BCR nanoclusters for signal propagation. Here we showed that all such translocations were impaired in the absence of Cav1, which suggests a connection among the BCR, Cav1 and actin reorganization after stimulation of the BCR. This connection might be mediated by the BCR-mediated recruitment of the phosphatase SHP2 to the membrane, which competes with CSK for binding to phosphorylated Cav1 (ref. 42) . CSK is thus released from the membrane, and the actin cytoskeleton relaxes. Alternatively, localization of the ERM ('ezrinradixin-moesin') family of actin-binding proteins to Cav1 and GM1-enriched domains 40 or the interaction of filamin A with Cav1 and actin 45 Here we demonstrated that the Tyr14 in Cav1 contributed to translocation of the IgM-BCR into and the IgD-BCR out of GM1-enriched domains, which opens a discussion of how ligand-induced BCR signaling and the phosphorylation of Cav1 regulate the reorganization of BCRs. Our data have conclusively shown that in Cav1-deficient B cells, IgM-BCR and IgD-BCR islands failed to coalesce after activation and that BCR signaling was impaired but not fully abolished. In contrast, IgM-BCR and IgD-BCR domains coalesced in B6.Cav1 Y14F/Y14F B cells, which showed a smaller reduction in activation than that of cells lacking Cav1 expression. Together these data suggest that the coalescence of IgM-BCRs and IgD-BCRs is a crucial step for efficient BCR signaling.
Despite their B cell dysfunction, aged B6.Cav1KO mice developed features of autoimmunity, such as spontaneous B cell activation, elevated autoantibody titers, a shorter lifespan and IgG deposits in the kidneys. Those hallmarks of autoimmunity were observed in two independent mouse models of Cav1 deficiency with different genetic backgrounds, as well as in BM-transfer experiments; this supports the proposal of their relevance. B cell-mediated autoimmunity has been 48 . However, we did not detect Cav1 expression in WEHI cells. After re-expression of Cav1, however, the IgM-BCR efficiently reorganized to GM1-enriched domains and enhanced IgM-induced apoptosis. Likewise, immature Cav1-deficient B cells failed to reorganize the IgM-BCR after stimulation or to initiate receptor editing by exchanging their LCs. Therefore, in both immature B cells and mature B cells, ligand-induced BCR reorganization is necessary for efficient signaling.
In summary, we have identified Cav1 as a regulator of the nanoscale organization of IgM-BCRs and IgD-BCRs in the plasma membrane of B cells. By targeting Cav1, we have demonstrated that nanoclustering of BCRs is crucial for setting the threshold of activation for both mature B cells and immature B cells. In immature B cells, the absence of Cav1 resulted in deficient counterselection of B cells expressing autoreactive BCRs, which ultimately led to autoimmunity in mice. This work underlines the emerging concept that immunodeficiency often manifests as autoimmunity, and will boost knowledge of diseases with dysregulation of the immune system.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
